WallStreetZenWallStreetZen

NASDAQ: XGN
Exagen Inc Stock Ownership - Who owns Exagen?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Exagen Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeffrey G. BlackChief Financial Officer2026-03-1275,000$3.16
$237.00kBuy
John AballiPresident and CEO2026-03-0315,698$3.62
$56.83kSell
John AballiPresident and CEO2026-03-032,535$3.08
$7.80kBuy
Jeffrey G. BlackChief Financial Officer2026-02-271,511$3.08
$4.65kBuy
John AballiPresident and CEO2026-02-2411,430$3.61
$41.26kSell
Jeffrey G. BlackChief Financial Officer2026-02-241,584$3.61
$5.72kSell
John AballiPresident and CEO2025-10-1631,787$11.82
$375.60kSell
Jeffrey G. BlackChief Financial Officer2025-09-0220,466$9.79
$200.36kSell

1 of 1

XGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XGN insiders and whales buy or sell their stock.

XGN Shareholders

What type of owners hold Exagen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James L. L. Tullis12.83%3,098,926$14.07MInsider
Nmsic Coinvestment Fund LP7.33%1,771,032$8.04MInsider
Hig Bioexagen LP7.02%1,696,252$7.70MInsider
Tullis Dickerson Capital Focus III LP6.73%1,625,264$7.38MInsider
Hunt Holdings Limited Partnership5.22%1,261,324$5.73MInsider
John Aballi3.64%880,235$4.00MInsider
Balyasny Asset Management LP3.30%796,632$3.62MInstitution
Wexford Capital LP3.28%792,855$3.60MInstitution
Acadian Asset Management LLC2.85%689,114$3.13MInstitution
Vanguard Capital Management LLC2.81%678,652$3.08MInstitution

1 of 3

XGN vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XGN40.04%46.87%Net Selling
BNR1.63%18.67%Net BuyingNet Buying
STIM54.58%45.42%Net SellingNet Buying
SERA50.93%25.28%Net SellingNet Selling
DRIO5.71%94.29%Net Buying
View Top Diagnostic & Research Stocks

Exagen Stock Ownership FAQ

Who owns Exagen?

Exagen (NASDAQ: XGN) is owned by 40.04% institutional shareholders, 46.87% Exagen insiders, and 13.09% retail investors. James L. L. Tullis is the largest individual Exagen shareholder, owning 3.10M shares representing 12.83% of the company. James L. L. Tullis's Exagen shares are currently valued at $14.07M.

If you're new to stock investing, here's how to buy Exagen stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.